Chinese American Hematologist And Oncologist Network Inc
Chinese American Hematologist And Oncologist Network Inc shows strong revenue and asset growth with no reported officer compensation.
EIN: 203662275 · Milwaukee, WI · NTEE: G30 · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $878K |
| Total Expenses | $581K |
| Program Spending | 90% |
| Net Assets | $1.2M |
| Transparency Score | 92/100 |
Is Chinese American Hematologist And Oncologist Network Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Chinese American Hematologist And Oncologist Network Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Chinese American Hematologist And Oncologist Network Inc
Chinese American Hematologist And Oncologist Network Inc (EIN: 203662275) is a nonprofit organization based in Milwaukee, WI, classified under NTEE code G30. The organization reported total revenue of $878K and total assets of $1.6M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Chinese American Hematologist And Oncologist Network Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Chinese American Hematologist And Oncologist Network Inc is a small nonprofit that has been operating for 16 years, with 10 years of IRS 990 filings on record (2014–2023). Revenue has grown at a compound annual rate of 26.6%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $825K |
| Total Expenses | $581K |
| Surplus / Deficit | +$244K |
| Total Assets | $1.3M |
| Total Liabilities | $114K |
| Net Assets | $1.2M |
| Operating Margin | 29.6% |
| Debt-to-Asset Ratio | 8.8% |
| Months of Reserves | 26.7 months |
Financial Health Grade: A
In 2023, Chinese American Hematologist And Oncologist Network Inc reported a surplus of $244K with revenue exceeding expenses, holds 26.7 months of operating reserves (strong position), has a debt-to-asset ratio of 8.8% (very low leverage).
Financial Trends
Over 10 years of filings (2014–2023), Chinese American Hematologist And Oncologist Network Inc's revenue has grown at a compound annual growth rate (CAGR) of 26.6%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -6.5% | -8.6% | +4.2% |
| 2022 | +56.5% | +137.0% | +27.3% |
| 2021 | +88.2% | +32.2% | +74.4% |
| 2020 | -9.4% | -22.0% | +19.4% |
| 2019 | +3.4% | -10.6% | +28.1% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2010 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Chinese American Hematologist And Oncologist Network Inc with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 7%
- programs: 90%
- fundraising: 3%
According to IRS 990 filings, Chinese American Hematologist And Oncologist Network Inc allocates its expenses as follows: admin: 7%, programs: 90%, fundraising: 3%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $244K, with revenue exceeding expenses.
- Debt-to-asset ratio: 8.8%.
Executive Compensation Analysis
The organization consistently reports 0% officer compensation across all available filings, indicating that no salaries are paid to its officers. This suggests a volunteer-driven leadership model, which significantly reduces administrative overhead and maximizes resources for programmatic activities.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for Chinese American Hematologist And Oncologist Network Inc:
- Consistent and significant revenue growth, from $98,496 in 2014 to $824,924 in 2023.
- Strong asset accumulation, growing from $86,722 in 2014 to $1,290,651 in 2023.
- 0% officer compensation reported across all filings, indicating high efficiency and volunteer leadership.
- Healthy financial reserves with assets significantly exceeding liabilities (e.g., $1,290,651 assets vs. $113,576 liabilities in 2023).
- Positive net income in most years, demonstrating financial sustainability (e.g., 2023 revenue $824,924 vs. expenses $580,572).
Frequently Asked Questions about Chinese American Hematologist And Oncologist Network Inc
Is Chinese American Hematologist And Oncologist Network Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Chinese American Hematologist And Oncologist Network Inc (EIN: 203662275) appears legitimate. Mission Score: 92/100. 0 red flags identified, 5 strengths noted.
How does Chinese American Hematologist And Oncologist Network Inc spend its money?
Chinese American Hematologist And Oncologist Network Inc directs 90% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Chinese American Hematologist And Oncologist Network Inc tax-deductible?
Chinese American Hematologist And Oncologist Network Inc is registered as a tax-exempt nonprofit (EIN: 203662275). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
What percentage of Chinese American Hematologist And Oncologist Network Inc's spending goes to programs?
Chinese American Hematologist And Oncologist Network Inc directs 90% to programs, 3% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.
How does Chinese American Hematologist And Oncologist Network Inc compare to similar nonprofits?
With a transparency score of 92/100 (Excellent), Chinese American Hematologist And Oncologist Network Inc is above average for NTEE category G30 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.
Where is Chinese American Hematologist And Oncologist Network Inc located?
Chinese American Hematologist And Oncologist Network Inc is headquartered in Milwaukee, Wisconsin and files with the IRS under EIN 203662275. It is classified under NTEE code G30.
How many years of IRS 990 filings does Chinese American Hematologist And Oncologist Network Inc have?
Chinese American Hematologist And Oncologist Network Inc has 10 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $878K in total revenue.
Is CAHON a good charity?
Based on the available IRS 990 data, CAHON appears to be a very good charity. It demonstrates strong financial growth, efficient spending with 0% officer compensation, and a clear focus on its mission by directing resources to programs.
How has CAHON's financial health changed over time?
CAHON's financial health has significantly improved over time. Revenue has grown from $98,496 in 2014 to $824,924 in 2023, and assets have increased from $86,722 to $1,290,651 in the same period, indicating robust and sustained growth.
What is CAHON's approach to executive compensation?
CAHON's approach to executive compensation is highly conservative, reporting 0% officer compensation in all available filings. This suggests a volunteer-led executive structure, which is a strong indicator of financial efficiency and dedication to its mission.
How does CAHON manage its liabilities?
CAHON's liabilities have fluctuated but remain well-managed relative to its assets. For example, in 2023, liabilities were $113,576 against assets of $1,290,651, indicating a healthy balance sheet and low financial risk.
Filing History
IRS 990 filing history for Chinese American Hematologist And Oncologist Network Inc showing financial trends over 10 years of public records:
Over 10 years of IRS 990 filings (2014–2023), Chinese American Hematologist And Oncologist Network Inc's revenue has grown by 737.5%, moving from $98K to $825K. Total assets increased by 1388.3% over the same period, from $87K to $1.3M. Total functional expenses rose by 1807.4%, from $30K to $581K. In its most recent filing year (2023), Chinese American Hematologist And Oncologist Network Inc reported a surplus of $244K, with revenue exceeding expenses. The organization holds $114K in liabilities against $1.3M in assets (debt-to-asset ratio: 8.8%), resulting in net assets of $1.2M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $825K | $581K | $1.3M | $114K | — | — |
| 2022 | $882K | $635K | $1.2M | $306K | — | View 990 |
| 2021 | $564K | $268K | $973K | $288K | — | View 990 |
| 2020 | $300K | $203K | $558K | $169K | — | — |
| 2019 | $331K | $260K | $468K | $175K | — | View 990 |
| 2018 | $320K | $290K | $365K | $50K | — | View 990 |
| 2017 | $180K | $112K | $286K | $0 | — | View 990 |
| 2016 | $159K | $52K | $218K | $0 | — | View 990 |
| 2015 | $117K | $93K | $111K | $0 | — | View 990 |
| 2014 | $98K | $30K | $87K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $825K, expenses of $581K, and assets of $1.3M (revenue -6.5% year-over-year).
- 2022: Revenue of $882K, expenses of $635K, and assets of $1.2M (revenue +56.5% year-over-year).
- 2021: Revenue of $564K, expenses of $268K, and assets of $973K (revenue +88.2% year-over-year).
- 2020: Revenue of $300K, expenses of $203K, and assets of $558K (revenue -9.4% year-over-year).
- 2019: Revenue of $331K, expenses of $260K, and assets of $468K (revenue +3.4% year-over-year).
- 2018: Revenue of $320K, expenses of $290K, and assets of $365K (revenue +78.1% year-over-year).
- 2017: Revenue of $180K, expenses of $112K, and assets of $286K (revenue +12.8% year-over-year).
- 2016: Revenue of $159K, expenses of $52K, and assets of $218K (revenue +35.9% year-over-year).
- 2015: Revenue of $117K, expenses of $93K, and assets of $111K (revenue +18.9% year-over-year).
- 2014: Revenue of $98K, expenses of $30K, and assets of $87K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Chinese American Hematologist And Oncologist Network Inc:
Data Sources and Methodology
This transparency report for Chinese American Hematologist And Oncologist Network Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.